Corporate News 11-Jan-24
Biocon to declare Quarterly Result
On 8 February 2024
Biocon will hold a meeting of the Board of Directors of the Company on 8 February 2024.
Previous News
Biocon's biologics arm gets Health Canada approval for aflibercept biosimilar 'Yesafili'
( Hot Pursuit - 27-Jun-25 12:18 )
Biocon raises Rs 4,500 crore via QIP
( Hot Pursuit - 21-Jun-25 09:13 )
Restaurant Brands Asia Ltd leads gainers in 'A' group
( Hot Pursuit - 19-Jun-25 12:00 )
Biocon get facilities rated
( Corporate News - 18-Jun-25 09:41 )
Indices drift lower in early trade; breadth positive
( Market Commentary - Mid-Session 17-Jun-25 09:37 )
Biocon Ltd soars 3.52%, Gains for third straight session
( Hot Pursuit - 11-Jun-25 13:05 )
Biocon gets CDSCO approval for Liraglutide drug substance
( Hot Pursuit - 03-Jun-25 08:23 )
Biocon Biologics announces extension of insulin supply agreement with Govt. of Malaysia
( Corporate News - 22-May-25 09:19 )
Biocon Ltd spurts 1.3%, up for five straight sessions
( Hot Pursuit - 19-May-25 13:00 )
Biocon's subsidiary get US FDA nod for anticoagulant medication Rivaroxaban
( Hot Pursuit - 16-May-25 09:38 )
Biocon
( Results - Analysis 09-May-25 10:36 )
Other Stories
Vintage Coffee And Beverages to hold board meeting
01-Jul-25 18:44
Hind Rectifiers to convene AGM
01-Jul-25 18:44
Lupin carves-out its LupinLife Consumer Healthcare
01-Jul-25 18:39
Lupin receives USFDA approval for Loteprednol Etabonate Ophthalmic Gel
01-Jul-25 18:37
LTIMindtree introduced its GCC-as-a-Service
01-Jul-25 18:34
Hyundai Motor India sells 60,924 units in June'25
01-Jul-25 18:33
Maruti Suzuki India records 6.26% decline in June sales
01-Jul-25 18:30
RateGain forges strategic partnership with Cloudbeds
01-Jul-25 15:24
Aurionpro Solutions announces strategic win with a leading UK-based financial institution
01-Jul-25 15:17
Tata Motors Q1 sales decline 8% to 2.10 lakh units
01-Jul-25 15:08
Back
Top
